JP2011509079A5 - - Google Patents

Download PDF

Info

Publication number
JP2011509079A5
JP2011509079A5 JP2010540186A JP2010540186A JP2011509079A5 JP 2011509079 A5 JP2011509079 A5 JP 2011509079A5 JP 2010540186 A JP2010540186 A JP 2010540186A JP 2010540186 A JP2010540186 A JP 2010540186A JP 2011509079 A5 JP2011509079 A5 JP 2011509079A5
Authority
JP
Japan
Prior art keywords
cancer
antibody
affinity reagent
receptor
ephrin type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010540186A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011509079A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2008/003634 external-priority patent/WO2009087462A2/en
Publication of JP2011509079A publication Critical patent/JP2011509079A/ja
Publication of JP2011509079A5 publication Critical patent/JP2011509079A5/ja
Pending legal-status Critical Current

Links

JP2010540186A 2007-12-24 2008-12-24 エフリンａ型受容体１０タンパク質 Pending JP2011509079A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US877507P 2007-12-24 2007-12-24
PCT/IB2008/003634 WO2009087462A2 (en) 2007-12-24 2008-12-24 Ephrin type-a receptor 10 protein

Publications (2)

Publication Number Publication Date
JP2011509079A JP2011509079A (ja) 2011-03-24
JP2011509079A5 true JP2011509079A5 (https=) 2012-02-16

Family

ID=40802031

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010540186A Pending JP2011509079A (ja) 2007-12-24 2008-12-24 エフリンａ型受容体１０タンパク質

Country Status (4)

Country Link
US (1) US8540998B2 (https=)
EP (1) EP2235055A2 (https=)
JP (1) JP2011509079A (https=)
WO (1) WO2009087462A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2470569A1 (en) * 2009-10-13 2012-07-04 Oxford Biotherapeutics Ltd. Antibodies against epha10
US8455200B2 (en) 2009-10-15 2013-06-04 Traxxsson, Llc Measurement of PKA for cancer detection
US20120282177A1 (en) 2009-11-02 2012-11-08 Christian Rohlff ROR1 as Therapeutic and Diagnostic Target
AU2011299088B2 (en) 2010-09-09 2015-12-24 Traxxsson, Llc Combination methods of diagnosing cancer in a patient
WO2012124334A1 (ja) * 2011-03-15 2012-09-20 独立行政法人医薬基盤研究所 抗体、乳がんの治療に用いられる医薬組成物、腫瘍検査方法、及び、腫瘍検査用試薬
RS55716B1 (sr) 2011-06-28 2017-07-31 Oxford Biotherapeutics Ltd Terapeutski i dijagnostički cilj
GB201213652D0 (en) 2012-08-01 2012-09-12 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
GB201302447D0 (en) 2013-02-12 2013-03-27 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
SI3055331T1 (sl) 2013-10-11 2021-04-30 Oxford Bio Therapeutics Limited Konjugirana protitelesa proti LY75 za zdravljenje raka
GB201703876D0 (en) 2017-03-10 2017-04-26 Berlin-Chemie Ag Pharmaceutical combinations
GB201809746D0 (en) 2018-06-14 2018-08-01 Berlin Chemie Ag Pharmaceutical combinations
JP2024540616A (ja) * 2021-11-22 2024-10-31 チャイナ メディカル ユニバーシティ エフリンａ型受容体１０に特異的な抗体、それを含有する融合タンパク質、それを発現するキメラ抗原受容体ｔ細胞及びその使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096952A1 (en) 2000-03-30 2003-05-22 Kumud Majumder Novel proteins and nucleic acids encoding same
US7074899B2 (en) * 2000-07-26 2006-07-11 Merck Patent Gmbh Human EphA9 receptor polypeptides
JP2003052384A (ja) 2001-04-06 2003-02-25 Takeda Chem Ind Ltd 新規レセプタータンパク質及びそのｄｎａ
EP1778726A4 (en) 2004-08-16 2009-03-18 Medimmune Inc INTEGRIN ANTAGONISTS WITH IMPROVED ANTIBODY-DEPENDENT CELL-ASSAYED CYTOTOXICITY ACTIVITY
US20060121042A1 (en) * 2004-10-27 2006-06-08 Medimmune, Inc. Modulation of antibody specificity by tailoring the affinity to cognate antigens
US20090304721A1 (en) 2005-09-07 2009-12-10 Medlmmune, Inc Toxin conjugated eph receptor antibodies
US20110008347A1 (en) 2006-12-01 2011-01-13 Agency For Science ,Technology And Research Cancer-related protein kinases

Similar Documents

Publication Publication Date Title
JP2011509079A5 (https=)
JP7674439B2 (ja) Ｇｆａｐとｕｃｈ－ｌ１との組合せを使用する、ヒト対象における外傷性脳損傷を診断及び査定する一助となるための方法
JP2010518847A5 (https=)
Huang et al. Nanobodies®: proficient tools in diagnostics
JP6715770B2 (ja) モノクローナル抗ｔｋ１抗体
JP6180931B2 (ja) 癌の診断および／または予後のための新規な抗体
JP2015172045A5 (https=)
JP2018042573A5 (https=)
JP2012523848A5 (https=)
JP2013506428A5 (https=)
JP2020522261A5 (https=)
JP2015516985A5 (https=)
CN110651190A (zh) 用早期生物标记物帮助确定是否对已遭受或可能已遭受头部损伤的人受试者执行成像的方法
JP2017518366A5 (https=)
CN110720041A (zh) 用心肌肌钙蛋白i和早期生物标记物帮助诊断和评价人受试者中轻度创伤性脑损伤的方法
JP2013520174A5 (https=)
JP2020534830A5 (https=)
JP2016500659A5 (https=)
JP2014529297A (ja) 新規な抗ｃｘｃｒ４抗体並びに癌の検出および診断のためのその使用
Kadonosono et al. Design strategy to create antibody mimetics harbouring immobilised complementarity determining region peptides for practical use
EP3094976A1 (en) Cell surface prostate cancer antigen for diagnosis
JP2010535506A5 (https=)
US12055552B2 (en) Method for diagnosis based on circulating extracellular vesicles
Dhaouadi et al. Novel human tenascin-C function-blocking camel single domain nanobodies
AU2016333540A1 (en) GDF-15 as a diagnostic marker for melanoma